MMJ Recs

APRIL 25, 2024

Testing Medical Cannabis for Quality Assurance: Testing medical cannabis is essential for ensuring product safety, potency, and compliance with regulatory standards. Microbiological Screening: Test for microbial contaminants such as bacteria, mold, and yeast to ensure product safety and compliance with health standards.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

NORML

MARCH 1, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. GA resident? GA resident? IN resident? MN resident?

Legislation 176

Legislation Compliance Compliance Hemp 176

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. 10] In the meantime, FDA has approved some requests for compassionate use. [11].

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

NORML

JANUARY 18, 2019

Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. AK resident? HI resident? CO resident? AZ resident?

Legislation 166

Legislation Decriminalization Access Therapy 166

MMJ Recs

MARCH 28, 2024

Whether you’re new to MMJ therapy or seeking renewal, this guide aims to empower patients with the knowledge needed to navigate the MMJ landscape in Iowa effectively. Finally, consider doctors who are knowledgeable about Iowa’s specific MMJ laws and regulations, ensuring compliance and seamless patient care.

Patients 52

Patients Treatment Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. NH resident? CO resident? New Hampshire.

Legislation 203

Legislation Decriminalization Hemp Patients 203

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

OCTOBER 2, 2021

We are currently focused on developing MDMA-assisted therapy as a Breakthrough Therapy for PTSD, with plans to submit for FDA approval in 2023. Team leadership: mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

NOVEMBER 23, 2021

Additionally, it validates the Company’s supply chain business model of providing psilocybin for clinical use and research, adding to previously announced supply partnerships this year with Mycrodose Therapeutics , Mycotopia Therapies , Cube Psytech , Allied Health , ATMA Journey Centers , Revive Therapeutics and HealthTech Connex.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

AUGUST 3, 2022

The lack of robust research on cannabis products, cannabis as a therapy and dependence or addiction to cannabis heightens the challenge of developing sound policies on the use of cannabis in health care facilities. Food and Drug Administration. Self-administration is prohibited. 1 See [link] and [link]. 2 [link]. 3 [link].

Research and Development 98

Research and Development Policy Patients Compliance 98

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. It is important to note that medical cannabis should only be used under the supervision of a healthcare provider and in compliance with state and federal laws.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

NORML

FEBRUARY 22, 2019

Senate Bill 1003 / House Bill 2273 to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. Legislation is pending, Senate Bill 8, as well as Senate Bill 598, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations.

Legislation 182

Legislation Hemp Compliance Compliance 182

Cannabis Law Report

MARCH 29, 2022

We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

MMJ Recs

FEBRUARY 21, 2024

Understanding the legal and regulatory landscape is essential to ensuring compliance and responsible use. Understanding the legal and regulatory landscape is equally important, ensuring compliance with local laws and access to safe, legal medical marijuana products.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

MJ Business Attorneys

JUNE 29, 2018

Marketing unapproved products, with uncertain dosages and formulations can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases” As CBD gains recognition as a medicine, the producers and manufacturers will be subject to strict regulatory policies, and noncompliance will not be tolerated.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MMJ Recs

SEPTEMBER 19, 2023

These clinics offer a wide range of services to address chronic pain, including advanced procedures and therapies. These solutions may include medication management, physical therapy, rehabilitation programs, and psychological support. Obtaining a medical marijuana card in Missouri involves a regulated and patient-centric process.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

JUNE 2, 2021

The Company is offering pooled surveillance testing in compliance with current CDC, FDA, and CMS guidances. The diagnostic kit has not been FDA cleared or approved, and the EUA’s limited authorization is only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

MAY 31, 2022

Two approaches apply to commercial operations—the traditional medical path and the emerging non-medical state-regulated path, while the other two paths are better seen as non-commercial—underground therapy and religious use. Breakthrough Therapy status obtained by COMPASS Pathways and Usona Institute. Breakthrough Therapy.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

JULY 13, 2021

LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. LEP) of Henderson, Nevada. We are deeply thankful to our founding team for getting us to this stage.”.

Research and Development 105

Research and Development Topical Cannabinoids Therapy 105

MMJ Recs

MARCH 2, 2024

Ohio Cannabis Dispensary Regulations Dispensaries must adhere to strict regulations set forth by the Ohio Medical Marijuana Control Program to ensure compliance and patient safety. By familiarizing yourself with Ohio’s medical marijuana laws and regulations, you can ensure compliance and eligibility for the program.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JANUARY 12, 2022

The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. Following the required transfer of Gb Sciences’ cannabis production and extraction licenses to AJE Management, LLC by the Nevada Cannabis Compliance Board on Dec. 31, 2021.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

NORML

MARCH 22, 2019

House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. Senate Bill 1353 seeks to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. CA resident? HI resident? HI resident? KS resident? MD resident?

Legislation 139

Legislation Hemp Patients Compliance 139

Cannabis Law Report

OCTOBER 10, 2021

We at Cantourage share the belief that cannabis is a valuable medicine which until now has not gained enough attention as a therapy option. Manage compliance to global, regional and local processes, policies, SOPs and working instructions. YOUR PROFILE: Bachelor’s degree in life science, relevant scientific field required (e.g.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

NORML

FEBRUARY 15, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. Legislation is pending, House Bill 131 / Senate Bill 1335, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. MT resident?

Legislation 166

Legislation Hemp Compliance Compliance 166

Cannabis Law Report

DECEMBER 9, 2021

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. NEW YORK , Dec. 9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. ” About MindMed. Forward-Looking Statements.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Veriheal

FEBRUARY 3, 2022

This gave doctors the freedom to recommend medical cannabis for any symptom, illness, or condition they felt cannabinoid therapies would be appropriate for. In addition to internal structural changes, there will be some staffing changes to address compliance issues that have plagued Oklahoma’s medical cannabis program.

Programs 52

Programs Seed-To-Sale Wellness and Beauty Compliance 52

Cannabis Law Report

JULY 24, 2021

Dr. Ahmad Doroudian, Chief Executive Officer of BetterLife, stated: “TD-010 is a potential novel therapy to treat debilitating anxiety disorders that show resistance to benzodiazepine and other therapies or require a long-term use and therefore put patients at risk for dependency.

Research and Development 98

Research and Development Treatment Therapy Media 98

NORML

MAY 24, 2019

The measure would permit physicians to recommend cannabis therapy to those diagnosed with anxiety, autism, opioid addiction or dependence, anorexia nervosa, among others. Legislation is pending, Senate Bill 347, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations.

Legislation 172

Legislation Hemp Access Patients 172

United Patients Group

OCTOBER 25, 2023

Navigating the complex world of medical marijuana can be challenging, particularly for individuals who are new to this alternative form of therapy. Patients using medical marijuana must familiarize themselves with their state’s specific regulations and guidelines to ensure they are in compliance with the law.

Marijuana 88

Marijuana Patients Research and Development Edibles 88

NORML

MAY 17, 2019

Legislation is pending, House Bill 824, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. The measure would permit physicians to recommend cannabis therapy to those diagnosed with anxiety, autism, opioid addiction or dependence, anorexia nervosa, among others. Update : S.

Legislation 139

Legislation Hemp Compliance Compliance 139

NORML

MARCH 15, 2019

Senate Bill 1353 seeks to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. Legislation is pending, HB 33 / SB 893, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. HI resident? LA resident? MD resident? MT resident?

Legislation 149

Legislation Hemp Compliance Compliance 149

Cannabis Law Report

AUGUST 17, 2021

Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Inhaled Vaccines, Cannabis, and Gene Therapy are the Innovative Applications under Research and Clinical Trial. The Strategic Imperative. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JUNE 16, 2019

Steve represents entities, governments and individuals in choosing a structure, preparing and submitting license application, regulation, compliance and litigation, and drafting legislation. – adding oil-based ( i.e. , vape cartridges) medical marijuana to available list.

Programs 77

Programs Chronic Pain Marijuana Conditions 77

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

MMJ Recs

APRIL 1, 2024

It’s essential for individuals interested in using CBD for medical purposes to stay informed about local regulations and consult legal experts for guidance on compliance and access to safe, legal CBD products. Keeping a detailed journal to track CBD dosage and its effects can aid in finding the optimal therapeutic dose.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

AUGUST 20, 2021

In an opinion piece published in The Times today , Conservative MP Dan Poulter, a practising NHS doctor, wrote that the drug has a lot of medical benefits – including the treatment of chronic pain, reduction of nausea for patients undergoing chemotherapy, and as a therapy for poor sleep and anxiety disorders.

Policy 105

Policy Chronic Pain Medicine Therapy 105